FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018409655> ?p ?o ?g. }

• W2018409655 endingPage "303" @default.
• W2018409655 startingPage "299" @default.
• W2018409655 abstract "ObjectiveThis study evaluated the feasibility, safety and 1-year results of mechanochemical endovenous ablation (MOCA™) of small saphenous vein (SSV) insufficiency.DesignProspective cohort study.Materials and methodsFifty consecutive patients were treated for primary SSV insufficiency with MOCA™ using the ClariVein® device and polidocanol. Initial technical success, complications, patient satisfaction and visual analogue scale (VAS) pain score were assessed. Anatomic and clinical success was assessed at 6 weeks and at 1 year.ResultsInitial technical success of MOCA™ was 100%. At the 6-week assessment, all treated veins were occluded. The 1-year follow-up duplex showed anatomic success in 94% (95% confidence interval, 0.87–1). Venous clinical severity score (VCSS) decreased significantly from 3.0 (interquartile range (IQR) 2–5) before treatment to 1.0 (IQR 1–3, P < 0.001) at 6 weeks and to 1.0 (IQR 1–2, P < 0.001) at 1 year. Median procedural VAS score for pain was 2 (IQR 2–4). No major complications were observed, especially no nerve injury.ConclusionsMOCA™ is a safe, feasible and efficacious technique for treatment of SSV insufficiency. One-year follow-up shows a 94% anatomic success rate and no major complications. This study evaluated the feasibility, safety and 1-year results of mechanochemical endovenous ablation (MOCA™) of small saphenous vein (SSV) insufficiency. Prospective cohort study. Fifty consecutive patients were treated for primary SSV insufficiency with MOCA™ using the ClariVein® device and polidocanol. Initial technical success, complications, patient satisfaction and visual analogue scale (VAS) pain score were assessed. Anatomic and clinical success was assessed at 6 weeks and at 1 year. Initial technical success of MOCA™ was 100%. At the 6-week assessment, all treated veins were occluded. The 1-year follow-up duplex showed anatomic success in 94% (95% confidence interval, 0.87–1). Venous clinical severity score (VCSS) decreased significantly from 3.0 (interquartile range (IQR) 2–5) before treatment to 1.0 (IQR 1–3, P < 0.001) at 6 weeks and to 1.0 (IQR 1–2, P < 0.001) at 1 year. Median procedural VAS score for pain was 2 (IQR 2–4). No major complications were observed, especially no nerve injury. MOCA™ is a safe, feasible and efficacious technique for treatment of SSV insufficiency. One-year follow-up shows a 94% anatomic success rate and no major complications." @default.
• W2018409655 created "2016-06-24" @default.
• W2018409655 creator A5004367806 @default.
• W2018409655 creator A5024112709 @default.
• W2018409655 creator A5029411852 @default.
• W2018409655 creator A5061498267 @default.
• W2018409655 creator A5061637031 @default.
• W2018409655 creator A5078444222 @default.
• W2018409655 date "2013-03-01" @default.
• W2018409655 modified "2023-10-12" @default.
• W2018409655 title "Mechanochemical Endovenous Ablation of Small Saphenous Vein Insufficiency Using the ClariVein® Device: One-year Results of a Prospective Series" @default.
• W2018409655 cites W1988260222 @default.
• W2018409655 cites W2016650672 @default.
• W2018409655 cites W2019477944 @default.
• W2018409655 cites W2027134819 @default.
• W2018409655 cites W2100951211 @default.
• W2018409655 cites W2107256754 @default.
• W2018409655 cites W2123446449 @default.
• W2018409655 cites W2128653466 @default.
• W2018409655 cites W2133672069 @default.
• W2018409655 cites W2139214811 @default.
• W2018409655 cites W2148449092 @default.
• W2018409655 cites W2156151548 @default.
• W2018409655 cites W2159731163 @default.
• W2018409655 cites W2161678681 @default.
• W2018409655 cites W2170110656 @default.
• W2018409655 cites W2170739230 @default.
• W2018409655 doi "https://doi.org/10.1016/j.ejvs.2012.12.004" @default.
• W2018409655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23312507" @default.
• W2018409655 hasPublicationYear "2013" @default.
• W2018409655 type Work @default.
• W2018409655 sameAs 2018409655 @default.
• W2018409655 citedByCount "71" @default.
• W2018409655 countsByYear W20184096552013 @default.
• W2018409655 countsByYear W20184096552014 @default.
• W2018409655 countsByYear W20184096552015 @default.
• W2018409655 countsByYear W20184096552016 @default.
• W2018409655 countsByYear W20184096552017 @default.
• W2018409655 countsByYear W20184096552018 @default.
• W2018409655 countsByYear W20184096552019 @default.
• W2018409655 countsByYear W20184096552020 @default.
• W2018409655 countsByYear W20184096552021 @default.
• W2018409655 countsByYear W20184096552022 @default.
• W2018409655 countsByYear W20184096552023 @default.
• W2018409655 crossrefType "journal-article" @default.
• W2018409655 hasAuthorship W2018409655A5004367806 @default.
• W2018409655 hasAuthorship W2018409655A5024112709 @default.
• W2018409655 hasAuthorship W2018409655A5029411852 @default.
• W2018409655 hasAuthorship W2018409655A5061498267 @default.
• W2018409655 hasAuthorship W2018409655A5061637031 @default.
• W2018409655 hasAuthorship W2018409655A5078444222 @default.
• W2018409655 hasBestOaLocation W20184096551 @default.
• W2018409655 hasConcept C119060515 @default.
• W2018409655 hasConcept C126322002 @default.
• W2018409655 hasConcept C141071460 @default.
• W2018409655 hasConcept C14184104 @default.
• W2018409655 hasConcept C188816634 @default.
• W2018409655 hasConcept C2775944032 @default.
• W2018409655 hasConcept C2776106345 @default.
• W2018409655 hasConcept C2776676729 @default.
• W2018409655 hasConcept C2777202286 @default.
• W2018409655 hasConcept C2777377203 @default.
• W2018409655 hasConcept C2777475103 @default.
• W2018409655 hasConcept C2778230777 @default.
• W2018409655 hasConcept C2778902805 @default.
• W2018409655 hasConcept C2780950165 @default.
• W2018409655 hasConcept C44249647 @default.
• W2018409655 hasConcept C71924100 @default.
• W2018409655 hasConceptScore W2018409655C119060515 @default.
• W2018409655 hasConceptScore W2018409655C126322002 @default.
• W2018409655 hasConceptScore W2018409655C141071460 @default.
• W2018409655 hasConceptScore W2018409655C14184104 @default.
• W2018409655 hasConceptScore W2018409655C188816634 @default.
• W2018409655 hasConceptScore W2018409655C2775944032 @default.
• W2018409655 hasConceptScore W2018409655C2776106345 @default.
• W2018409655 hasConceptScore W2018409655C2776676729 @default.
• W2018409655 hasConceptScore W2018409655C2777202286 @default.
• W2018409655 hasConceptScore W2018409655C2777377203 @default.
• W2018409655 hasConceptScore W2018409655C2777475103 @default.
• W2018409655 hasConceptScore W2018409655C2778230777 @default.
• W2018409655 hasConceptScore W2018409655C2778902805 @default.
• W2018409655 hasConceptScore W2018409655C2780950165 @default.
• W2018409655 hasConceptScore W2018409655C44249647 @default.
• W2018409655 hasConceptScore W2018409655C71924100 @default.
• W2018409655 hasIssue "3" @default.
• W2018409655 hasLocation W20184096551 @default.
• W2018409655 hasLocation W20184096552 @default.
• W2018409655 hasOpenAccess W2018409655 @default.
• W2018409655 hasPrimaryLocation W20184096551 @default.
• W2018409655 hasRelatedWork W2018409655 @default.
• W2018409655 hasRelatedWork W2058257354 @default.
• W2018409655 hasRelatedWork W2164956589 @default.
• W2018409655 hasRelatedWork W2364043227 @default.
• W2018409655 hasRelatedWork W2959362854 @default.
• W2018409655 hasRelatedWork W3010816387 @default.
• W2018409655 hasRelatedWork W3021837994 @default.
• W2018409655 hasRelatedWork W3085685983 @default.
• W2018409655 hasRelatedWork W3172327768 @default.

• next